Clinical Trials Browser

Phase NA × HR+/HER2- Advanced Breast Cancer × dalpiciclib × Clear all

NCT06711094 2024-12-02

Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC

Phase NA Not yet recruiting

HR+/HER2- Advanced Breast Cancer